Sarepta Therapeutics, Inc. SRPT Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $730.8M+65.0% | $442.93M+10.9% | $399.36M-34.6% | $611.09M-18.0% | $744.86M— | ||
| $330.96M+217% | -$282.85M-57.2% | -$179.95M— | —— | -$447.51M-381% | ||
| 45.3%+109pp | -63.9%-18.8pp | -45.1%— | —— | -60.1%— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Sarepta Therapeutics, Inc.'s income statement data come from?
- Every line is extracted from Sarepta Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.